Besides providing novel insights into the molecular mechanisms of BRD4 inhibition in the regulation of PD-1 expression and PD-1-mediated inhibition of T-cell function, this study inspires thought on the dual effect of target inhibition BRD4 for cancer immunotherapy. The gene discussed is BRD4; the disease is cancer.